Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
GZPHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $75 | $76 | $71 | $69 |
| % Growth | -0.7% | 6.7% | 2.6% | – |
| Cost of Goods Sold | $62 | $61 | $58 | $56 |
| Gross Profit | $13 | $14 | $13 | $13 |
| % Margin | 16.7% | 18.8% | 18.8% | 19.2% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $1 | $1 | $1 | $0 |
| SG&A Expenses | $3 | $3 | $6 | $6 |
| Sales & Mktg Exp. | $2 | $3 | $6 | $6 |
| Other Operating Expenses | $5 | $5 | $1 | $2 |
| Operating Expenses | $9 | $9 | $9 | $9 |
| Operating Income | $4 | $5 | $5 | $5 |
| % Margin | 4.8% | 6.8% | 7.2% | 6.9% |
| Other Income/Exp. Net | $0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $4 | $5 | $5 | $5 |
| Tax Expense | $1 | $1 | $1 | $1 |
| Net Income | $3 | $4 | $4 | $4 |
| % Margin | 3.8% | 5.4% | 5.6% | 5.4% |
| EPS | 1.74 | 2.49 | 2.44 | 2.29 |
| % Growth | -30.1% | 2% | 6.6% | – |
| EPS Diluted | 1.74 | 2.49 | 2.44 | 2.29 |
| Weighted Avg Shares Out | 2 | 2 | 2 | 2 |
| Weighted Avg Shares Out Dil | 2 | 2 | 2 | 2 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $1 | $1 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | $5 | $6 | $6 | $6 |
| % Margin | 6.5% | 8.6% | 8.9% | 8.3% |